In this webcast we will present Agilent samples to answers workflow solutions for monoclonal antibody characterization. The presentation covers analytical strategies for monitoring CQAs. We will focus on main quality attributes such as charge variants, aggregation, glycosylation, host cell protein impurities and post-translational modifications. Live: Europe: Wednesday, Feb. 5, 2020 at 2pm GMT | 3pm CET US: Wednesday, Feb. 5, 2020 at 2pm EST | 1pm CST | 11am PST On demand available after final airing until Feb. 5, 2021 Register free
Register free:http://www.chromatographyonline.com/lcgc_w/advanced_analytical
Event Overview:
Complex recombinant monoclonal antibodies (mAbs) are a growing class of biotherapeutics. mAbs are susceptible to chemical modification and degradation during production, formulation, and storage, and thus, identifying critical quality attributes (CQAs) is critical for development and production of biotherapeutics. Ensuring lot-to-lot consistency and quality of the product requires comprehensive analytical characterization.
In this webcast we will present Agilent samples to answers workflow solutions for monoclonal antibody characterization. The presentation covers analytical strategies for monitoring CQAs. We will focus on main quality attributes such as charge variants, aggregation, glycosylation, host cell protein impurities and post-translational modifications.
Key Learning Objectives:
Speaker: Dr. Suresh Babu C.V., Ph.D., Solution Development Scientist, Agilent Technologies
Time and Date: Europe: Wednesday, Feb. 5, 2020 at 2pm GMT | 3pm CET
US: Wednesday, Feb. 5, 2020 at 2pm EST | 1pm CST | 11am PST
On demand available after final airing until Feb. 5, 2021
Sponsor: Agilent Technologies
Register free: http://www.chromatographyonline.com/lcgc_w/advanced_analytical